Quality of life questionnaire for pulmonary arterial hypertension
Part of Lungs & breathing clinical trials.
This study aims to develop a new questionnaire to measure how pulmonary arterial hypertension affects daily life. It may help patients and doctors better understand the condition's impact.
Summary written for real people, not researchers, by Clin2.
Who can take part
- 18 years or older
- Diagnosed with pulmonary arterial hypertension
- Able to read and fill out questionnaires
- Willing to provide informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to validate a questionnaire that measures how well patients understand pulmonary hypertension. If you have been diagnosed with Group 1 Pulmonary Arterial Hypertension (PAH) and can read the questionnaire, you may be able to help researchers make sure it's a useful tool.
This study is testing a questionnaire (EMPHASIS-10) to measure quality of life in people with pulmonary hypertension. The goal is to adapt it for Brazilian Portuguese speakers so doctors can better understand how the disease affects daily life.
This study asks people with pulmonary hypertension and their caregivers about where they get information about the condition. The goal is to understand what sources you use so that doctors can provide better information in the future.
This study measures how heart procedures affect quality of life for both patients and their caregivers, using simple questionnaires.
This study looks at how environmental factors (like pollutants and lifestyle) may affect pulmonary hypertension. You will fill out questionnaires and provide a small hair sample to help understand these exposures.
This study is tracking people with pulmonary hypertension (high blood pressure in the lungs) over time to see how their condition and quality of life change. By joining, you help doctors better understand the disease and improve care for others like you.
Hear when a new Pulmonary Arterial Hypertension (PAH) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.